May RB, Sunder TR, Caldwell P.Hematologic changes in valproate monotherapy. Epilepsia. 1989; 30:699-700.
2.
Ganick DJ, Sunder T., Finley JLSevere hematologic toxicity of valproic acid. Am J Pediatr Hematol OncoL.1990 ;1:80-85.
3.
Brichard B., Vermylen C., Scheiff JM, et al. Hematologic disturbances during long-term valproate therapy . Eur J Pediatr.1994;153:378-380.
4.
Dreifuss FE, Langer DHSide effects ofvalproate. Am J Med.1988;84:34-41.
5.
Sandler RM, Emberson C., Roberts GE, et al. IgM platelet autoantibody due to sodium valproate. Br Med J.1978;2:1683-1684.
6.
Tattenborn B. , Luth G., Krämer G.Valproate-induced leukopenia. Epilepsia. 1990;31:227-228.
7.
Kaya IS, Dilmen U., Toppare M., et al. Valproic acid-induced pancytopenia and Coombs test positivity . Lancet. 1991;337:1227-1228.
8.
MacDougall LG. Pure red cell aplasia associated with sodium valproate therapy. JAMA.1982;247:53-54.
9.
Watts RG, Emanuel PD, Zuckerman KS, Howard THValproic acid-induced cytopenia: evidence for a dose-related suppression of hematopoiesis. J Pediatr.1990;117:495-499.
10.
Ozkara C., Dreifuss FE, Apperson HCChanges in red blood cells with valproate. Acta Neurol Scand.1993;99:210-212.
11.
Davis RG, Sunder TR, Barakat HA, May R.Valproate alters the phospholipids of erythrocytes. Epilepsia . 1991;32 (suppl3):11-12.
12.
Rajantie J. , Kajosaari M., Ylitalo V.Fatal pancytopenia during high dose valproate monotherapy. Eur J Pediatr.1992;151:619-620.
